The effect of n-3 fatty acids on coronary atherosclerosis: Results from SCIMO, an angiographic study, background and implications

Lipids

Volumn 36, Issue SUPPL., 2001, Pages

  Von Schacky, C ^a   Baumann, K ^a   Angerer, P ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; DISEASES; PATHOLOGY;

CORONARY ARTERY DISEASE;

FATTY ACIDS;

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIETARY INTAKE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0035704185     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-001-0689-5     Document Type: Conference Paper

References (26)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Atherosclerosis - An inflammatory disease
3. The oxidation hypothesis of atherosclerosis
4. Endothelial dysfunction in atherosclerosis
5. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association
6. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
7. Atherosclerosis, basic mechanisms, oxidation, inflammation, and genetics
8. Growth factors and endothelial dysfunction
9. Synergistic induction of monocyte chemoattractant protein-1 (MCP-1) by platelet-derived growth factor and interleukin-1
10. Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy
11. n-3 fatty acids and the prevention of coronary atherosclerosis
12. n-3 polyunsaturated fatty acids and the cardiovascular system
13. Dietary ω-3 fatty acids lower levels of platelet-derived growth factor mrna in human mononuclear cells
14. Dietary ω-3, ω-6, and ω-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study
15. The effect of dietary ω-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial
16. Growth factor mRNA profiles in unstimulated human mononuclear cells: Identification of genes which are constitutively and variably expressed
17. Individual fatty acids in the british household food supply
18. Quantitative coronary angiography
19. Comparative in vitro validation of eight first- and second-generation quantitative coronary angiography systems
20. Dietary ω-3 fatty acids and human carotid atherosclerosis in patients with coronary artery disease: Results of a randomized double-blind two-year intervention trial
21. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells
22. Omega-3 fatty acids and endothelial leukocyte adhesion molecules
23. Dietary polyunsaturated fatty acid regulation of gene transcription
24. Differential effects of n-6 and n-3 polyunsaturated fatty acids on cell growth and early gene expression in swiss 3T3 fibroblasts
25. Regression of atherosclerosis. Does it occur and does it have a clinical meaning?
26. Controlled trial of fish oil for regression of human coronary atherosclerosis